Study about the prognosis factor of rhythm control treatment in patients with supraventricular tachycardia

Study about the prognosis factor of rhythm control treatment in patients with supraventricular tachycardia - Study about the prognosis factor of rhythm control treatment in patients with supraventricular tachycardia

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029638

Enrollment

1000

Registered

2017-10-20

Start date

2017-09-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

supraventricular tachycardia (atrial fibrillation, atrial tachycardia etc.)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with supraventricular tachycardia (atrial fibrillation, atrial tachycardia etc.). Patients not younger than 20 years old (at the time of informed consent) Genders do not matter.

Exclusion criteria

Exclusion criteria: Patients who were judged to be inappropriate for this study.

Design outcomes

Primary

Measure	Time frame
To elucidate the key prognosis factor of rhythm control treatment (electric defibrillation,electric cardioversion, catheter ablation)	—

Countries

Japan

Contacts

Public ContactIchitaro Abe

Faculty of Medicine, Oita University Department of Cardiology and Clinical Examination

i-taro@oita-u.ac.jp097-586-5974

Outcome results